← Back to headlines
Sleep Drug Developer Apnimed Rises on Trading Debut
Apnimed, a company specializing in the development of sleep drugs, saw its stock rise significantly on its trading debut.
31 Jul, 16:28 — 31 Jul, 16:28
Sources
Showing 1 of 1 sources
